Literature DB >> 23547267

Meta-analysis of amyloid-cognition relations in cognitively normal older adults.

Trey Hedden1, Hwamee Oh, Alayna P Younger, Tanu A Patel.   

Abstract

OBJECTIVE: We conducted a meta-analysis of relationships between amyloid burden and cognition in cognitively normal, older adult humans.
METHODS: Methods of assessing amyloid burden included were CSF or plasma assays, histopathology, and PET ligands. Cognitive domains examined were episodic memory, executive function, working memory, processing speed, visuospatial function, semantic memory, and global cognition. Sixty-four studies representing 7,140 subjects met selection criteria, with 3,495 subjects from 34 studies representing independent cohorts. Weighted effect sizes were obtained for each study. Primary analyses were conducted limiting to independent cohort studies using only the most common assessment method (Pittsburgh compound B). Exploratory analyses included all assessment methods.
RESULTS: Episodic memory (r = 0.12) had a significant relationship to amyloid burden. Executive function and global cognition did not have significant relationships to amyloid in the primary analysis of Pittsburgh compound B (r = 0.05 and r = 0.08, respectively), but did when including all assessment methods (r = 0.08 and r = 0.09, respectively). The domains of working memory, processing speed, visuospatial function, and semantic memory did not have significant relationships to amyloid. Differences in the method of amyloid assessment, study design (longitudinal vs cross-sectional), or inclusion of control variables (age, etc.) had little influence.
CONCLUSIONS: Based on this meta-analytic survey of the literature, increased amyloid burden has small but nontrivial associations with specific domains of cognitive performance in individuals who are currently cognitively normal. These associations may be useful for identifying preclinical Alzheimer disease or developing clinical outcome measures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547267      PMCID: PMC3656457          DOI: 10.1212/WNL.0b013e31828ab35d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  Face-name associative memory performance is related to amyloid burden in normal elderly.

Authors:  Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2011-06-12       Impact factor: 3.139

2.  Effects of age and β-amyloid on cognitive changes in normal elderly people.

Authors:  Hwamee Oh; Cindee Madison; Thaddeus J Haight; Candace Markley; William J Jagust
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

3.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

4.  APOE modifies the association between Aβ load and cognition in cognitively normal older adults.

Authors:  K Kantarci; V Lowe; S A Przybelski; S D Weigand; M L Senjem; R J Ivnik; G M Preboske; R Roberts; Y E Geda; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2011-12-21       Impact factor: 9.910

Review 5.  Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues.

Authors:  Lars Bäckman; Ulman Lindenberger; Shu-Chen Li; Lars Nyberg
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

6.  Nutrient intake and plasma β-amyloid.

Authors:  Y Gu; N Schupf; S A Cosentino; J A Luchsinger; N Scarmeas
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

Review 7.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

Review 8.  Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Authors:  G D Rabinovici; W J Jagust
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

9.  Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.

Authors:  Hwamee Oh; Christian Habeck; Cindee Madison; William Jagust
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

10.  Alzheimer's disease: synaptic dysfunction and Abeta.

Authors:  Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Neurodegener       Date:  2009-11-23       Impact factor: 14.195

View more
  144 in total

1.  Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.

Authors:  Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris
Journal:  J Int Neuropsychol Soc       Date:  2015-09       Impact factor: 2.892

2.  Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Authors:  Daniela Bertens; Dirk L Knol; Philip Scheltens; Pieter Jelle Visser
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

3.  The effect of beta-amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal.

Authors:  Jenny R Rieck; Karen M Rodrigue; Kristen M Kennedy; Michael D Devous; Denise C Park
Journal:  Hum Brain Mapp       Date:  2015-04-02       Impact factor: 5.038

4.  Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.

Authors:  Miranka Wirth; Claudia M Haase; Sylvia Villeneuve; Jacob Vogel; William J Jagust
Journal:  Neurobiol Aging       Date:  2014-02-20       Impact factor: 4.673

5.  Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Authors:  Michelle M Mielke; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Mary M Machulda; Davis S Knopman; Val Lowe; Rosebud O Roberts; Kejal Kantarci; Walter A Rocca; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2014-11-15       Impact factor: 21.566

6.  Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.

Authors:  Ashwati Vipin; Kwun Kei Ng; Fang Ji; Hee Youn Shim; Joseph K W Lim; Ofer Pasternak; Juan Helen Zhou
Journal:  Hum Brain Mapp       Date:  2019-01-03       Impact factor: 5.038

7.  Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.

Authors:  Hwamee Oh; Jason Steffener; Qolamreza R Razlighi; Christian Habeck; Dan Liu; Yunglin Gazes; Sarah Janicki; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2015-08-24       Impact factor: 4.673

8.  Patterns of cognitive function in aging: the Rotterdam Study.

Authors:  Yoo Young Hoogendam; Albert Hofman; Jos N van der Geest; Aad van der Lugt; Mohammad Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2014-02-20       Impact factor: 8.082

9.  Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.

Authors:  Murat Bilgel; Yang An; Jessica Helphrey; Wendy Elkins; Gabriela Gomez; Dean F Wong; Christos Davatzikos; Luigi Ferrucci; Susan M Resnick
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 10.  Is amyloid-β harmful to the brain? Insights from human imaging studies.

Authors:  William Jagust
Journal:  Brain       Date:  2015-11-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.